A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether low dose (renal dose) dopamine in the critically ill patient prevents acute renal failure. Altogether 141 papers were found using the reported search, of which three presented the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of these papers are tabulated. We conclude that there is no evidence to support the use of low-dose dopamine to treat acute renal failure in critically ill patients. q
Introduction
A best evidence topic was constructed according to a structured protocol. This protocol is fully described in the ICVTS [1] .
Clinical scenario
You are asked to review a 75-year-old patient who is 1 day post coronary arterial bypass surgery. He has passed 8 ml of urine in the last hour and only 70 ml in the last 6 h. Of note he had 40 mg of Frusemide 1 h ago. His pulse is 95 and he is in sinus rhythm, his blood pressure is 105/70 and his CVP is 5 cm. He has no history of renal failure and he is on no reno-toxic drugs, although he is on a small dose of noradrenaline. You note that it had been a difficult operation and there had been a long bypass time. You suggest an increase in the noradrenaline to increase his blood pressure and thus his renal perfusion pressure. The nurse suggests that you try a 'renal dose of dopamine' instead. You do not believe that dopamine is actually reno-protective and thus you elect to search for the evidence for or against this commonly held view.
Three part question
In 
Search outcome
One hundred and forty-one papers were found of which 24 were included in the meta-analysis reported below [2] . Two further papers were found which were relevant [3 -4] . One hundred and twelve abstracts were irrelevant and three were of insufficient quality for inclusion. The relevant papers are presented in Table 1 . Included here as it is a similar quality paper to those in the meta-analysis but this was not included by Kellum and Decker [2] 6. Comment(s)
The meta-analysis by Kellum et al. could demonstrate no benefit of low dose dopamine for the preservation of renal function. This was a well conducted meta-analysis, however, of 53 relevant papers found, data could only be extracted from half of the reviewed papers.
We also found two more recently published trials not included in this meta-analysis. These also presented negative results. The ANZICS trial found no reno-protective effect with dopamine, and the NORASEPT II study also found no reno-protective effect.
The meta-analysis and the two randomised controlled trials presented here find that there is no reno-protective effect with dopamine. To ensure that there has not been a type I error (finding no difference when in fact one does exist) the papers must be adequately powered. Kellum et al. provide power calculations showing that they are very unlikely to have missed benefits to renal failure of over 50%.
However, even this meta-analysis is not able to exclude smaller effects than this. Our calculations show that to detect a 20% difference in acute renal failure (control event rate from this meta-analysis was 19.5%) with a power of 80%, one would need 4100 patients for a double blind RCT, or meta-analysis.
Thus, while it can firmly concluded that dopamine does not halve the rate of acute renal failure, it is currently unknown as to whether dopamine might have a smaller positive effect than this. In order to exclude a 20% reduction in acute renal failure with dopamine, a randomised controlled trial would have to recruit 4100 critically ill patients.
Clinical bottom line
There is no evidence to support the use of low-dose dopamine to treat acute renal failure in critically ill patients.
Prins et al, and this paper would certainly help clinicians working with neonates to answer their questions on the effectiveness of low dose dopamine for renoprotection.
BestBET topics are not systematic reviews but we believe that with our multi-stage checking process and sensitive and reproducible search strategies that we can quickly answer relevant clinical questions that we see in our daily practise and that the findings will be robust and reliable. The true strength however is that these topics can be written by everyone who has an interest in improving their clinical practise. So if you have a question that you want answering just read how to write a BET [1] , sit down with Medline, get writing and send it to the ICVTS!
